An article on open science for a general audience. - Michael Nielsen

Cameron Neylon, Jean-Claude Bradley and Sabine Hossenfelder all get extensively quoted. Nice to see! - Michael Nielsen

indeed - thanks for bookmarking Michael - Jean-Claude Bradley

The exciting news to me is that the "public" is interested in this. The article is being, clipped, dug, etc. - michael sean wright

Most excellent -- one quibble, I'd like to see "no insider information" credited to Jean-Claude. - Bill Hooker

well thanks Bill - the author removed it after some reformatting of the original paragraph :) I didn't ask for it to be removed - I have no problem with that paragraph - Jean-Claude Bradley

so you think that private company will always permits to their scientist to share data with the rest of the world? - Piero Giacomelli

@Piero: some will, some won't. The hypothesis is that the sharing model will prove more efficient, so early adopters will realize an advantage and eventually the mainstream will adopt their methods. There are no guarantees but I think it's worth testing the hypothesis. - Bill Hooker

Depends on the information. Pharma companies are already sharing pre-competitive information. Stuff that they would need to repeat in the absence of any data availability. With things like GWAS, it might be impossible to do for a company, so they will collaborate with universities and make the raw data public (e.g. Novartis) - Deepak Singh

Expression data (eQTL) too. See Rosetta/Merck. - Chris Cotsapas

@Chris, oops. Should have included that one esp cause I have used that in talks :) (I was at Rosetta Biosoftware) - Deepak Singh